Evoke Pharma, Inc.
Q2 2024 13F Holders
Symbol
EVOK
CUSIP
30049G203
Type
Equity
Class
COM NEW
Num filings
19
Total reported value, excl. options
$2.02 M
Compare 2024 Q2 to
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
2022 Q4
2022 Q3
2022 Q2
Manager
Report Date
Value ($000)
Shares
Option Type